SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-285680
Filing Date
2019-11-06
Accepted
2019-11-06 13:50:28
Documents
2
Group Members
FHMLS IX, L.L.C.FHMLS IX, L.P.JAMES TOPPERPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d827064dsc13d.htm SC 13D 123329
2 EX-99.A d827064dex99a.htm EX-99.A 8787
  Complete submission text file 0001193125-19-285680.txt   133751
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences IX, L.P. (Filed by) CIK: 0001720320 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 650-325-5156
Phathom Pharmaceuticals, Inc. (Subject) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91182 | Film No.: 191195845
SIC: 2834 Pharmaceutical Preparations